Background Hidradenitis suppurativa (HS) is a, chronic skin disease affecting up to 1% of
the population in Europe. This study aims to assess the cost-of-illness of HS from a societal …

Pemphigus vulgaris is a chronic autoimmune mucocutaneous blistering disorder. Apart from
the disease itself, other aspects of patients' life, including psychological, social, and …

Background Cost-of-illness studies are widely used for healthcare decision-making in
chronic conditions. Our aim was to assess the cost-of-illness of adult atopic dermatitis (AD) …

Abstract Background Pulmonary Arterial Hypertension (PAH) is a rare, debilitating, and
potentially fatal disease. This study aims to quantify the economic burden of PAH in Spain …

COVID‐19 is a serious multisystem disease caused by severe acute respiratory syndrome
coronavirus 2. Due to the COVID‐19 crisis, that still keeps its impacts worldwide, numerous …

Introduction Economic evaluations typically focus solely on patient-specific costs with
economic spillovers to informal caregivers less frequently evaluated. This may …

Background Data on trends in epidemiological characteristics and economic burden of
pemphigus are scarce. Objective To describe national trends in pemphigus' incidence …

Background The National Health Commission and the other relevant departments in China
have initiated testing of the Diagnosis Related Groups (DRGs) system in 30 pilot locations …

Importance There is an increasing body of literature that supports the use of rituximab as a
first-line steroid-sparing agent in pemphigus vulgaris. However, the cost of rituximab is …

Introduction: Le pemphigus pose un défi thérapeutique avec une morbidité et une charge
économique élevées. La prescription du rituximab en première ligne reste limitée en Tunisie …